Aqr Capital Management LLC Athenex, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $24,105 - $53,501	58,793 Added 116.07%	109,447 $45,000
Q1 2022 May 16, 2022	BUY	$0.79 - $1.59 $13,411 - $26,993	16,977 Added 50.41%	50,654 $42,000
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $45,800 - $99,010	33,677 New	33,677 $46,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $37,971 - $61,879	-12,785 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $47,432 - $65,587	12,785 New	12,785 $59,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.